"Discussions with potential customers for the project’s scandium are continuing. Indicative off-take outcomes will be assessed as part of the Scoping Study’s production scenarios, to be released in coming months."
I think these guys are lot more advanced than we think. Keiser is on the ball - his no.1 tip last yr was a scandium stock and it flew 500% on his recomendation. It's a big coup for Friedland however as he was onto it ages ago with Ivanhoe - now CLQ are in the box seat to capitalise.
CLQ Price at posting:
11.0¢ Sentiment: None Disclosure: Held
